BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19725139)

  • 1. More tumor-affected lymph nodes because of the sentinel lymph node procedure but no stage migration, because the 2002 TNM classifies small tumor deposits as pathologic N0 breast cancer.
    Bolster MJ; Bult P; Wauters CA; Strobbe LJ; Peer PG; Wobbes T; Tjan-Heijnen VC
    Cancer; 2009 Dec; 115(23):5589-95. PubMed ID: 19725139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
    Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
    Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of sentinel lymph node biopsy in the pathologic staging of colorectal cancer patients.
    Bertoglio S; Sandrucci S; Percivale P; Goss M; Gipponi M; Moresco L; Mussa B; Mussa A
    J Surg Oncol; 2004 Mar; 85(3):166-70. PubMed ID: 14991889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
    Gipponi M
    Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in sentinel lymph node pathology protocols lead to differences in surgical strategy in breast cancer patients.
    Bolster MJ; Bult P; Schapers RF; Meijer JW; Strobbe LJ; van Berlo CL; Klinkenbijl JH; Peer PG; Wobbes T; Tjan-Heijnen VC
    Ann Surg Oncol; 2006 Nov; 13(11):1466-73. PubMed ID: 17009158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma.
    Nieuwenhuis EJ; van der Waal I; Leemans CR; Kummer A; Pijpers R; Castelijns JA; Brakenhoff RH; Snow GB
    Head Neck; 2005 Feb; 27(2):150-8. PubMed ID: 15627261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the sentinel node procedure to stage endometrial cancer.
    Ballester M; Dubernard G; Rouzier R; Barranger E; Darai E
    Ann Surg Oncol; 2008 May; 15(5):1523-9. PubMed ID: 18322758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of the sentinel lymph node procedure in patients with large size breast cancer.
    Lelievre L; Houvenaeghel G; Buttarelli M; Brenot-Rossi I; Huiart L; Tallet A; Tarpin C; Jacquemier J
    Ann Surg Oncol; 2007 Feb; 14(2):621-6. PubMed ID: 17103062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast sentinel lymph node dissection before preoperative chemotherapy.
    Grube BJ; Christy CJ; Black D; Martel M; Harris L; Weidhaas J; Digiovanna MP; Chung G; Abu-Khalaf MM; Miller KD; Higgins SA; Philpotts L; Tavassoli FA; Lannin DR
    Arch Surg; 2008 Jul; 143(7):692-9; discussion 699-700. PubMed ID: 18645113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
    Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic examination of sentinel lymph nodes in breast cancer by a single haematoxylin-eosin slide versus serial sectioning and immunocytokeratin staining: clinical implications.
    Groen RS; Oosterhuis AW; Boers JE
    Breast Cancer Res Treat; 2007 Sep; 105(1):1-5. PubMed ID: 17221160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study.
    Bolster MJ; Peer PG; Bult P; Thunnissen FB; Schapers RF; Meijer JW; Strobbe LJ; van Berlo CL; Klinkenbijl JH; Beex LV; Wobbes T; Tjan-Heijnen VC
    Ann Surg Oncol; 2007 Jan; 14(1):181-9. PubMed ID: 17028772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients.
    Degnim AC; Griffith KA; Sabel MS; Hayes DF; Cimmino VM; Diehl KM; Lucas PC; Snyder ML; Chang AE; Newman LA
    Cancer; 2003 Dec; 98(11):2307-15. PubMed ID: 14635063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-classification of sentinel lymph node predicts axillary nonsentinel lymph node status in patients with breast cancer.
    Fink AM; Lass H; Hartleb H; Jurecka W; Salzer H; Steiner A
    Ann Surg Oncol; 2008 Mar; 15(3):848-53. PubMed ID: 18043975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph-node biopsy compared to axillary lymph-node dissection for axillary staging in breast cancer patients.
    Schrenk P; Shamiyeh A; Wayand W
    Eur J Surg Oncol; 2001 Jun; 27(4):378-82. PubMed ID: 11417984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
    J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
    Martel P; Capdet J; Méry E; Zerdoud S; Ferron G; Rafii A; Roché H; Querleu D
    Bull Cancer; 2008; 95(7):763-72. PubMed ID: 18755653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
    van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.